[2P-0820] Anti-inflammatory and anti-cancer effect of Dicentrine via down-regulated NF-κB activity

〇Supachai Yodkeeree¹, Pornngarm Limtrakul¹ (1.Department of Biochemistry, Faculty of Medicine, Chiangmai University, Chiang Mai 50200, Thailand)

ConBio2017

[2P-0821] NIR-Stimulated Single-Walled Carbon Nanotube (SWCNT)-Mediated Cancer Therapy and its Long-Term Biodistribution

〇Mariah Mikhaela C. Chua¹, Jobi F. Subosa¹, Kamila Isabelle A. Navarro¹, Cynthia P. Saloma¹ (1.National Institute of Molecular Biology and Biotechnology, College of Science, University of the Philippines Diliman, Quezon City 1101, Philippines)

ConBio2017

[2P-0822] HL156A, a new metformin derivative, prevents cancer progression by inhibiting the IGF/Akt/mTOR pathways in oral cancer cells

Thuy Giang Lam¹, 〇Sang-Gun Ahn¹ (1.Department of Pathology, School of Dentistry, Chosun University, Gwangju, 61452, Republic of Korea)

ConBio2017

[2P-0823] Search for novel molecular targeted compound for suppression of metastasis in non-small cell lung cancer

〇Nami Miura¹, Kaoru Onidani¹, Hirokazu Shoji¹, Hideaki Shiraishi¹, Kazufumi Honda^1,2 (1.Dept. of Biomar. Early Det. Cancer, Natl Cancer Ctr. Res. Inst., 2.AMED, CREST)

ConBio2017

[2P-0824] Novel anticancer strategy based on the characteristics of NAD⁺ biosynthetic pathway in cancer cells

〇Yusuke Takai¹, Akira Sato¹, Youko Ogino¹, Kiyotaka Katuragi¹, Tetsuya Yamamoto², Atsushi Yoshimori², Takahiro Oyama³, Hideaki Abe³, Sei-ichi Tanuma¹ (1.Fac. Pharm. Sci., Tokyo Univ. Sci., 2.Institute for Theoretical Medicine, Inc., 3.Hinoki shinyaku Co., Ltd.)

ConBio2017

[2P-0825] An exploration of somatic mutations located in Exonic Splicing Enhancers using The Cancer Genome Atlas

〇Kousuke Tanimoto¹ (1.Genome Lab., Medical Res. Inst., Tokyo Medical and Dental Univ.)

ConBio2017

[2P-0826] Identification of CPIG7.2 as a candidate for triple-negative breast cancer-associated gene through pan-cancer analysis

〇Shoichiro Tange¹, Kiyoshi Masuda¹, Tomohiro Kohmoto¹, Masako Saito¹, Issei Imoto¹ (1.Dept. of Hum. Genet., Grad. Sch. Biomed.Sci., Tokushima Univ.)

ConBio2017

[2P-0827] Prostate cancer gene therapy by adenovirus-SOCS3 and combination therapy with immune cell therapy enhanced antitumor effect

〇Tomomi Yoneda¹, Hiroki Saito², Yuka Fukui¹, Koichi Kitagawa², Satoshi Serada³, Tetsuji Naka³, Toshiro Shirakawa^1,2 (1.Div. of Adv. Med. Sci., Grad. Sch. of Sci., Tec., and Inn., Univ. of Kobe, 2.Grad. Sch. of Med., Univ. of Kobe, 3.Nat. Inst. of Biomed. Inno., Heal. and Nutr.)

ConBio2017

[2P-0828] Identification of a long non-coding RNA associated with gastric cancer

〇Hiroshi Kitajima¹, Reo Maruyama², Eiichiro Yamamoto^1,3, Takeshi Niinuma¹, Masahiro Kai¹, Takashi Tokino⁴, Hiroshi Nakase³, Hiromu Suzuki¹ (1.Dept. Mol. Biol., Sapporo. Med. Univ., 2.Project Cancer Epigenome, The Cancer Inst., Japanese Foundation Cancer, 3.Dept., Gastroentrol. Hepatol. Sapporo. Med. Univ., 4.Medical. Genome. Sci., Res. Inst. Frontier Med., Sapporo. Med. Univ.)

ConBio2017

[2P-0829] Screening for pancreatic cancer stem cell niche-mimicking synthetic polymers

〇Yoshitaka Murota¹, Sara Schmidt², Kouichi Tabu¹, Hiromitsu Ito³, Shinji Tanaka^3,4, Mark Bradley², Tetsuya Taga¹ (1.Dept. of Stem Cell Regulation, Med. Res. Inst., Tokyo Med. & Dental Univ. (TMDU), 2.High-Throughput Chemical Biology, Sch. of Chemistry, Univ. of Edinburgh, 3.Dept. of Hepato-Billary-Pancreatic Surgery, Grad. Sch. of Medicine, Tokyo Med. & Dental Univ. (TMDU), 4.Dept. of Molecular Oncology, Grad. Sch. of Medicine, Tokyo Med. & Dental Univ. (TMDU))

ConBio2017